BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19234532)

  • 1. The role of INI1/hSNF5 in gene regulation and cancer.
    Stojanova A; Penn LZ
    Biochem Cell Biol; 2009 Feb; 87(1):163-77. PubMed ID: 19234532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrase interactor 1 in health and disease.
    Das S
    Curr Protein Pept Sci; 2015; 16(6):478-90. PubMed ID: 25772157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
    Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
    Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function.
    Cheng SW; Davies KP; Yung E; Beltran RJ; Yu J; Kalpana GV
    Nat Genet; 1999 May; 22(1):102-5. PubMed ID: 10319872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC interaction with the tumor suppressive SWI/SNF complex member INI1 regulates transcription and cellular transformation.
    Stojanova A; Tu WB; Ponzielli R; Kotlyar M; Chan PK; Boutros PC; Khosravi F; Jurisica I; Raught B; Penn LZ
    Cell Cycle; 2016 Jul; 15(13):1693-705. PubMed ID: 27267444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of INI1/hSNF5 RPT1 and its interactions with the c-MYC:MAX heterodimer provide insights into the interplay between MYC and the SWI/SNF chromatin remodeling complex.
    Sammak S; Allen MD; Hamdani N; Bycroft M; Zinzalla G
    FEBS J; 2018 Nov; 285(22):4165-4180. PubMed ID: 30222246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity.
    Boese A; Sommer P; Holzer D; Maier R; Nehrbass U
    J Gen Virol; 2009 Oct; 90(Pt 10):2503-2512. PubMed ID: 19515827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
    Caramel J; Medjkane S; Quignon F; Delattre O
    Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters.
    Kuwahara Y; Wei D; Durand J; Weissman BE
    Mol Cancer Res; 2013 Mar; 11(3):251-60. PubMed ID: 23364536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes.
    Doan DN; Veal TM; Yan Z; Wang W; Jones SN; Imbalzano AN
    Oncogene; 2004 Apr; 23(19):3462-73. PubMed ID: 14990991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin-remodeling factor INI1/hSNF5/BAF47 is involved in activation of the colony stimulating factor 1 promoter.
    Pan X; Song Z; Zhai L; Li X; Zeng X
    Mol Cells; 2005 Oct; 20(2):183-8. PubMed ID: 16267391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of a protein-protein interaction between INI1 and c-Myc by small peptidomimetic molecules inspired by Helix-1 of c-Myc: identification of a new target of potential antineoplastic interest.
    Bagnasco L; Tortolina L; Biasotti B; Castagnino N; Ponassi R; Tomati V; Nieddu E; Stier G; Malacarne D; Parodi S
    FASEB J; 2007 Apr; 21(4):1256-63. PubMed ID: 17215484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of DNA binding property of the HIV-1 host factor and tumor suppressor protein Integrase Interactor 1 (INI1/hSNF5).
    Das S; Banerjee B; Hossain M; Thangamuniyandi M; Dasgupta S; Chongdar N; Kumar GS; Basu G
    PLoS One; 2013; 8(7):e66581. PubMed ID: 23861745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.
    Caramel J; Quignon F; Delattre O
    Cancer Res; 2008 Aug; 68(15):6154-61. PubMed ID: 18676838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.
    Versteege I; Medjkane S; Rouillard D; Delattre O
    Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rad4-Rad23 interaction with SWI/SNF links ATP-dependent chromatin remodeling with nucleotide excision repair.
    Gong F; Fahy D; Smerdon MJ
    Nat Struct Mol Biol; 2006 Oct; 13(10):902-7. PubMed ID: 17013386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a monoclonal antibody for INI1/hSNF5/BAF47.
    Harada A; Hayashi M; Kuniyoshi Y; Semba Y; Sugahara S; Tachibana T; Ohkawa Y; Fujita M
    Monoclon Antib Immunodiagn Immunother; 2014 Feb; 33(1):49-51. PubMed ID: 24555937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization.
    Medjkane S; Novikov E; Versteege I; Delattre O
    Cancer Res; 2004 May; 64(10):3406-13. PubMed ID: 15150092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA.
    Lee D; Sohn H; Kalpana GV; Choe J
    Nature; 1999 Jun; 399(6735):487-91. PubMed ID: 10365963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler.
    Woodley CM; Romer AS; Wang J; Guarnaccia AD; Elion DL; Maxwell JN; Guerrazzi K; McCann TS; Popay TM; Matlock BK; Flaherty DK; Lorey SL; Liu Q; Tansey WP; Weissmiller AM
    Oncogene; 2021 May; 40(20):3593-3609. PubMed ID: 33931740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.